Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 10092 | 9.04 |
09:36 ET | 842 | 9.04 |
09:38 ET | 698 | 9 |
09:39 ET | 300 | 8.98 |
09:41 ET | 1158 | 9 |
09:43 ET | 343 | 9.01 |
09:45 ET | 897 | 9.04 |
09:48 ET | 700 | 9.02 |
09:50 ET | 200 | 9.03 |
09:52 ET | 219 | 9.015 |
09:54 ET | 565 | 8.9695 |
09:56 ET | 820 | 9.01 |
09:57 ET | 253 | 9.02 |
09:59 ET | 320 | 9.02 |
10:01 ET | 2042 | 9.01 |
10:03 ET | 1000 | 8.99 |
10:06 ET | 500 | 8.98 |
10:08 ET | 200 | 8.99 |
10:10 ET | 2451 | 9.03 |
10:12 ET | 700 | 9.01 |
10:14 ET | 100 | 9 |
10:15 ET | 800 | 8.9899 |
10:17 ET | 200 | 8.97 |
10:21 ET | 400 | 8.98 |
10:24 ET | 119 | 8.98 |
10:26 ET | 500 | 8.96 |
10:28 ET | 1180 | 8.95 |
10:30 ET | 100 | 8.93 |
10:32 ET | 284 | 8.944 |
10:33 ET | 100 | 8.93 |
10:35 ET | 400 | 8.945 |
10:37 ET | 800 | 8.97 |
10:39 ET | 100 | 8.98 |
10:42 ET | 405 | 8.98 |
10:44 ET | 2709 | 8.95 |
10:46 ET | 1584 | 8.94 |
10:48 ET | 350 | 8.93 |
10:50 ET | 700 | 8.9298 |
10:51 ET | 1199 | 8.92 |
10:53 ET | 5297 | 8.9 |
10:55 ET | 4130 | 8.91 |
10:57 ET | 2136 | 8.92 |
11:00 ET | 200 | 8.92 |
11:02 ET | 2721 | 8.911 |
11:04 ET | 4971 | 8.91 |
11:06 ET | 1000 | 8.89 |
11:08 ET | 5831 | 8.9 |
11:09 ET | 500 | 8.9 |
11:11 ET | 699 | 8.9 |
11:13 ET | 4868 | 8.89 |
11:15 ET | 500 | 8.9 |
11:18 ET | 613 | 8.9 |
11:20 ET | 3930 | 8.89 |
11:22 ET | 7487 | 8.88 |
11:24 ET | 2312 | 8.89 |
11:26 ET | 1621 | 8.91 |
11:27 ET | 2200 | 8.915 |
11:29 ET | 1876 | 8.9001 |
11:31 ET | 3300 | 8.91 |
11:33 ET | 1971 | 8.9 |
11:36 ET | 1779 | 8.888 |
11:38 ET | 100 | 8.88 |
11:40 ET | 1849 | 8.898 |
11:42 ET | 500 | 8.88 |
11:44 ET | 3918 | 8.88 |
11:47 ET | 100 | 8.882 |
11:49 ET | 2800 | 8.845 |
11:51 ET | 500 | 8.85 |
11:54 ET | 2800 | 8.8375 |
11:56 ET | 2954 | 8.85 |
11:58 ET | 500 | 8.84 |
12:00 ET | 8146 | 8.83 |
12:02 ET | 14382 | 8.83 |
12:03 ET | 1419 | 8.83 |
12:05 ET | 4756 | 8.84 |
12:07 ET | 556 | 8.855 |
12:09 ET | 500 | 8.86 |
12:12 ET | 1400 | 8.86 |
12:14 ET | 3594 | 8.855 |
12:16 ET | 3152 | 8.8575 |
12:18 ET | 4764 | 8.89 |
12:20 ET | 3283 | 8.885 |
12:21 ET | 5735 | 8.86 |
12:23 ET | 100 | 8.85 |
12:25 ET | 1450 | 8.8375 |
12:27 ET | 1164 | 8.845 |
12:30 ET | 1534 | 8.85 |
12:32 ET | 507 | 8.8405 |
12:34 ET | 5733 | 8.82 |
12:36 ET | 4570 | 8.84 |
12:39 ET | 200 | 8.84 |
12:41 ET | 600 | 8.845 |
12:43 ET | 600 | 8.845 |
12:45 ET | 400 | 8.845 |
12:48 ET | 707 | 8.845 |
12:50 ET | 423 | 8.845 |
12:52 ET | 4377 | 8.84 |
12:54 ET | 920 | 8.81 |
12:56 ET | 200 | 8.81 |
12:57 ET | 10723 | 8.82 |
12:59 ET | 200 | 8.815 |
01:01 ET | 13141 | 8.8 |
01:03 ET | 248 | 8.7999 |
01:06 ET | 5749 | 8.7963 |
01:08 ET | 3681 | 8.79 |
01:10 ET | 100 | 8.79 |
01:12 ET | 1726 | 8.82 |
01:14 ET | 200 | 8.82 |
01:17 ET | 554 | 8.81 |
01:19 ET | 500 | 8.81 |
01:21 ET | 200 | 8.81 |
01:24 ET | 3054 | 8.78 |
01:26 ET | 2480 | 8.78 |
01:28 ET | 4826 | 8.77 |
01:30 ET | 850 | 8.76 |
01:32 ET | 3194 | 8.775 |
01:33 ET | 1738 | 8.79 |
01:35 ET | 257 | 8.79 |
01:37 ET | 3126 | 8.796 |
01:39 ET | 5659 | 8.81 |
01:42 ET | 600 | 8.795 |
01:44 ET | 2306 | 8.78 |
01:46 ET | 1150 | 8.785 |
01:48 ET | 600 | 8.78 |
01:50 ET | 1553 | 8.77 |
01:51 ET | 600 | 8.778 |
01:53 ET | 686 | 8.775 |
01:57 ET | 2411 | 8.785 |
02:00 ET | 2700 | 8.795 |
02:02 ET | 3861 | 8.82 |
02:04 ET | 5266 | 8.83 |
02:06 ET | 2450 | 8.84 |
02:08 ET | 100 | 8.85 |
02:09 ET | 7986 | 8.85 |
02:11 ET | 500 | 8.845 |
02:13 ET | 2766 | 8.835 |
02:15 ET | 6131 | 8.83 |
02:18 ET | 9077 | 8.8401 |
02:20 ET | 4400 | 8.8401 |
02:22 ET | 11941 | 8.85 |
02:24 ET | 3200 | 8.8601 |
02:26 ET | 1391 | 8.86 |
02:27 ET | 8500 | 8.85 |
02:29 ET | 9732 | 8.86 |
02:31 ET | 7668 | 8.855 |
02:33 ET | 4200 | 8.87 |
02:36 ET | 6839 | 8.91 |
02:38 ET | 12098 | 8.89 |
02:40 ET | 798 | 8.895 |
02:42 ET | 14349 | 8.9 |
02:44 ET | 2005 | 8.905 |
02:45 ET | 1453 | 8.92 |
02:47 ET | 400 | 8.9101 |
02:49 ET | 1803 | 8.91 |
02:51 ET | 2350 | 8.8882 |
02:54 ET | 4503 | 8.88 |
02:56 ET | 850 | 8.86 |
02:58 ET | 3452 | 8.86 |
03:00 ET | 1000 | 8.86 |
03:02 ET | 3869 | 8.885 |
03:03 ET | 200 | 8.885 |
03:05 ET | 725 | 8.885 |
03:07 ET | 2167 | 8.88 |
03:09 ET | 1525 | 8.88 |
03:12 ET | 4557 | 8.88 |
03:14 ET | 2252 | 8.85 |
03:16 ET | 300 | 8.86 |
03:18 ET | 1400 | 8.88 |
03:20 ET | 1382 | 8.875 |
03:21 ET | 300 | 8.875 |
03:23 ET | 5490 | 8.875 |
03:25 ET | 7428 | 8.89 |
03:27 ET | 1236 | 8.885 |
03:30 ET | 4362 | 8.895 |
03:32 ET | 1672 | 8.895 |
03:34 ET | 1142 | 8.895 |
03:36 ET | 2775 | 8.885 |
03:38 ET | 3425 | 8.86 |
03:39 ET | 7924 | 8.86 |
03:41 ET | 6857 | 8.87 |
03:43 ET | 3970 | 8.865 |
03:45 ET | 2342 | 8.89 |
03:48 ET | 2844 | 8.87 |
03:50 ET | 3399 | 8.875 |
03:52 ET | 8836 | 8.875 |
03:54 ET | 5431 | 8.895 |
03:56 ET | 29907 | 8.855 |
03:57 ET | 8448 | 8.85 |
03:59 ET | 47527 | 8.85 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Prothena Corporation PLC | 1.1B | -6.3x | --- |
Nurix Therapeutics Inc | 1.1B | -7.1x | --- |
Immatics NV | 1.2B | -11.5x | --- |
Ardelyx Inc | 1.2B | -18.3x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.2x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
---|---|
Revenue (TTM) | $79.6M |
Shares Outstanding | 136.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-4.01 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 15.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -780.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.